SCHEMBL10748416

SCHEMBL10748416

CC(C)(C)c1nnc(-n2[se]c3ccccc3c2=O)s1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 7/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ QSOX1 O00391 1/20 0.48
▸ RGS12 O14924 1/20 0.48
▸ PMM2 O15305 1/20 0.48
▸ PLIN1 O60240 1/20 0.48
▸ GMNN O75496 1/20 0.48
▸ BBOX1 O75936 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ TP53 P04637 1/20 0.48
▸ CYBB P04839 1/20 0.48
▸ BCHE P06276 1/20 0.48
▸ GLA P06280 1/20 0.48
▸ POLB P06746 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2D6 P10635 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ G6PD P11413 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10764046 0.86 METAP2 (0.48) METAP2KDM4EMEN1QSOX1RGS12
SCHEMBL10746138 0.85 ALDH1A1 (0.35) METAP2KDM4EMEN1QSOX1RGS12
SCHEMBL10746484 0.82 METAP2 (0.54) METAP2KDM4EMEN1QSOX1RGS12
SCHEMBL10745605 0.79 METAP2 (0.51) METAP2KDM4EMEN1QSOX1RGS12
SCHEMBL10742993 0.71 METAP2 (0.53) METAP2KDM4EMEN1QSOX1RGS12
SCHEMBL1906226 0.71 MPI (0.55) KDM4EMEN1PMM2ALDH1A1TP53
SCHEMBL10747704 0.71 HTT (0.41) METAP2KDM4EMEN1QSOX1RGS12
SCHEMBL5916647 0.70 EP300 (0.55) METAP2KDM4EMEN1QSOX1RGS12
SCHEMBL5916972 0.70 KAT2A (0.57) METAP2KDM4EMEN1QSOX1RGS12
SCHEMBL5916659 0.70 METAP2 (0.51) METAP2KDM4EMEN1QSOX1RGS12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
US-4550168-A Benzisoselenazolones and a process for the treatment of inflammatory diseases A. NATTERMANN & CIE GMBH (DE) 1985-10-29 — — US disclosed
EP-0100899-A2 Benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them A. Nattermann & Cie. GmbH (DE) 1984-02-22 — — EP disclosed
Send feedback